GO:0047159 plasmalogen synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0047159 (plasmalogen synthase activity) catalyzes the acylation of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine to form 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine, using acyl-CoA as the acyl donor.
• The reaction is a key late step in plasmalogen biosynthesis, converting a lysoplasmalogen intermediate into the mature vinyl-ether phospholipid.
• Enzyme activity has been measured in mammalian heart mitochondria and microsomes, where both alkenyl-GPC and acyl-GPC acceptors are acylated.
• A bacterial plasmalogen synthase, MeHAD from Megasphaera elsdenii, has been characterized and heterologously expressed, enabling recombinant production of plasmalogens.
• Facultative anaerobic bacteria can produce plasmalogens, and recombinant Escherichia coli expressing anaerobic bacterium-derived plasmalogen synthase genes can synthesize plasmalogens aerobically.
• The enzyme belongs to the acyltransferase family and is distinct from acyl-GPC acyltransferases, although both use acyl-CoA and lysophospholipid acceptors.
Description
Plasmalogen synthase activity (GO:0047159) is a molecular function that catalyzes the transfer of an acyl group from acyl-CoA to the sn-2 position of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine, producing 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine and free CoA. This reaction is part of the plasmalogen biosynthetic pathway, which generates vinyl-ether phospholipids that are abundant in heart and brain membranes. The term is defined in QuickGO as the catalysis of this specific acyltransferase reaction, and it is synonymous with 1-alkenylglycerophosphocholine O-acyltransferase activity and acyl-CoA:1-alkenylglycerophosphocholine O-acyltransferase activity. Researchers study plasmalogen synthase activity because plasmalogens are critical for membrane structure, antioxidant defense, and cellular signaling, and because defects in plasmalogen metabolism are linked to neurological and metabolic disorders. The enzyme provides a tractable target for biochemical assays using radiolabeled acyl-CoA or mass spectrometry, and its bacterial homologs have been exploited for heterologous plasmalogen production. Understanding this activity helps clarify how cells maintain plasmalogen pools and how microbial systems can be engineered to synthesize these lipids. The activity has been documented in guinea pig heart mitochondria and microsomes, where both 1-alkenyl-GPC and 1-acyl-GPC are acylated by distinct acyltransferases. These studies established that plasmalogen synthase activity is separable from acyl-GPC acyltransferase activity and that it prefers alkenyl-GPC substrates. More recent work has identified and characterized a bacterial plasmalogen synthase, MeHAD, and demonstrated plasmalogen production in facultative anaerobic bacteria and recombinant E. coli.
plasmalogen synthase activity At A Glance
| GO ID | GO:0047159 |
|---|---|
| GO term | plasmalogen synthase activity |
| Ontology | molecular_function |
| Synonym | 1-alkenylglycerophosphocholine O-acyltransferase activity; acyl-CoA:1-alkenylglycerophosphocholine O-acyltransferase activity |
| Major function | Acyl-CoA-dependent acylation of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine to form 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine |
| Reaction | 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine + an acyl-CoA = 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine + CoA |
| Substrate | 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine (lysoplasmalogen) and acyl-CoA |
| Product | 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine and CoA |
| Cellular context | Membrane-associated activity detected in mitochondria and microsomes of mammalian tissues |
| Representative enzyme | MeHAD from Megasphaera elsdenii, a characterized bacterial plasmalogen synthase |
What Is GO:0047159?
Plasmalogen synthase activity (GO:0047159) is the catalytic activity that transfers an acyl group from an acyl-CoA donor to the sn-2 hydroxyl of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine, yielding 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine and CoA. In other words, it is an O-acyltransferase that converts a lysoplasmalogen (1-alkenyl-GPC) into a mature plasmalogen by adding a fatty acid at the second position of the glycerol backbone. The reaction is part of the broader plasmalogen remodeling and biosynthesis network and is distinct from the acylation of 1-acyl-GPC, which is catalyzed by separate acyltransferases.
Why Is plasmalogen synthase activity Important in Cell Biology?
Plasmalogen synthase activity is important because it completes the synthesis of mature plasmalogens, a class of ether phospholipids that are essential for membrane organization, antioxidant protection, and signaling in heart, brain, and other tissues. The reaction provides a biochemical entry point to study plasmalogen homeostasis, and its bacterial homologs enable heterologous production of these valuable lipids for research and industrial applications. Because plasmalogen levels are altered in several disease states, measuring and manipulating this activity can help define causal links between plasmalogen metabolism and human pathology.
• Plasmalogen synthase activity generates mature plasmalogens, which are major constituents of heart and brain membranes.
• The reaction is a late step in plasmalogen biosynthesis and is required to convert lysoplasmalogen intermediates into functional phospholipids.
• Assays of this activity in guinea pig heart mitochondria and microsomes have provided foundational knowledge on plasmalogen remodeling.
• The bacterial enzyme MeHAD enables heterologous expression and recombinant plasmalogen production.
• Facultative anaerobic bacteria and recombinant E. coli can produce plasmalogens when expressing anaerobic plasmalogen synthase genes.
• The activity is distinct from acyl-GPC acyltransferases, allowing selective targeting in biochemical studies.
• Plasmalogen deficiency is associated with neurological and metabolic disorders, making this activity a potential therapeutic target.
• Measuring plasmalogen synthase activity can help interpret lipidomic changes in disease models.
• The enzyme provides a tool for engineering microbial lipid production.
• Understanding its substrate specificity can guide development of selective inhibitors or activators.
Molecular Mechanism of plasmalogen synthase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the lysoplasmalogen and an acyl-CoA molecule.
Plasmalogen synthase activity uses 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine as the acyl acceptor and an acyl-CoA as the acyl donor. The enzyme must recognize the vinyl-ether bond at the sn-1 position, which distinguishes the substrate from the more common 1-acyl-glycerophosphocholine. Studies in guinea pig heart showed that both alkenyl-GPC and acyl-GPC can be acylated, but by distinct enzyme activities, indicating that plasmalogen synthase has specificity for the alkenyl species.
Catalytic acyl transfer
In simple terms: The enzyme moves the fatty acid from acyl-CoA onto the lysoplasmalogen.
The catalytic step involves transfer of the acyl group from acyl-CoA to the sn-2 hydroxyl of the lysoplasmalogen, releasing CoA. This O-acylation reaction converts the lysoplasmalogen into a mature plasmalogen with a fatty acid at the sn-2 position. The reaction is analogous to other acyl-CoA-dependent acyltransferase reactions but is specific for the alkenyl-GPC acceptor.
Cofactors and co-substrates
In simple terms: The enzyme needs acyl-CoA as the fatty acid carrier.
Acyl-CoA serves as the acyl donor and is consumed in the reaction, producing CoA as a byproduct. No other cofactors are specified in the QuickGO definition, and the reaction does not require ATP or other energy sources beyond the thioester bond of acyl-CoA. The acyl-CoA species can vary, providing different fatty acids for the sn-2 position.
Membrane association and cellular location
In simple terms: The enzyme works in cell membranes, especially in mitochondria and microsomes.
Plasmalogen synthase activity has been detected in guinea pig heart mitochondria and microsomes, where it associates with membrane fractions. The activity in mitochondria and microsomes can be distinguished by substrate preference and kinetic properties, suggesting multiple enzymes or isoforms. This membrane localization places the enzyme near the sites of plasmalogen synthesis and remodeling.
Bacterial plasmalogen synthase and heterologous expression
In simple terms: Bacteria have their own version of the enzyme that can be used to make plasmalogens in the lab.
A plasmalogen synthase from Megasphaera elsdenii, termed MeHAD, has been characterized and heterologously expressed, enabling recombinant plasmalogen production. Facultative anaerobic bacteria can produce plasmalogens, and recombinant Escherichia coli expressing anaerobic bacterium-derived plasmalogen synthase genes can synthesize plasmalogens aerobically. These findings demonstrate that the catalytic activity is conserved across domains of life and can be transferred to heterologous hosts.
Key Genes Involved in GO:0047159 plasmalogen synthase activity
The following genes and proteins are directly associated with plasmalogen synthase activity or its biochemical characterization.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MeHAD (Megasphaera elsdenii) | Bacterial plasmalogen synthase that catalyzes acyl transfer to lysoplasmalogen | Characterized and heterologously expressed for plasmalogen production |
| Plasmalogen synthase genes from facultative anaerobes | Encode enzymes that produce plasmalogens in anaerobic bacteria | Expressed in E. coli for aerobic plasmalogen synthesis |
| Acyl-GPC acyltransferase (mammalian) | Acylates 1-acyl-GPC, distinct from plasmalogen synthase | Used to differentiate plasmalogen synthase activity from general acyl-GPC acylation |
| Alkenyl-GPC acyltransferase (guinea pig heart mitochondria) | Acylates 1-alkenyl-GPC in mitochondria | Biochemical source for measuring plasmalogen synthase activity |
| Alkenyl-GPC acyltransferase (guinea pig heart microsomes) | Acylates 1-alkenyl-GPC in microsomes | Provides microsomal activity for comparison with mitochondrial enzyme |
| Alkenyl-GPE acyltransferase (guinea pig heart microsomes) | Acylates 1-alkenyl-glycerophosphoethanolamine | Related activity for plasmalogen synthesis in the ethanolamine pathway |
| Acyl-CoA synthetase (contextual) | Generates acyl-CoA substrates for acyltransferases | Supplies acyl-CoA for plasmalogen synthase assays |
| CoA (cofactor) | Acyl carrier released during the reaction | Product of the reaction and marker of enzyme activity |
| 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine (substrate) | Lysoplasmalogen acceptor | Substrate used in enzyme assays |
| 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine (product) | Mature plasmalogen | Measured as readout of enzyme activity |
| MeHAD homologs in anaerobic bacteria | Potential plasmalogen synthases | Targets for heterologous expression and engineering |
| E. coli host genes (background) | Provide metabolic context for recombinant plasmalogen synthesis | Used as chassis for expressing plasmalogen synthase genes |
How Is plasmalogen synthase activity Regulated?
Plasmalogen synthase activity is regulated at the level of substrate availability and enzyme expression. The reaction depends on the availability of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine and acyl-CoA, which are generated by upstream metabolic pathways. In mammalian tissues, the activity is distributed between mitochondria and microsomes, suggesting compartment-specific regulation. The bacterial enzyme MeHAD is expressed under conditions that support plasmalogen production, and heterologous expression in E. coli can be controlled by promoter systems. No specific transcription factors or signaling pathways are defined in the QuickGO entry for this activity, so regulation is primarily inferred from biochemical studies.
plasmalogen synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MeHAD (Megasphaera elsdenii) | Plasmalogen production for biotechnology | Recombinant E. coli expressing MeHAD |
| Facultative anaerobic bacterial plasmalogen synthase genes | Aerobic plasmalogen synthesis | Recombinant E. coli with anaerobic synthase genes |
| Mammalian alkenyl-GPC acyltransferase | Cardiac plasmalogen metabolism | Guinea pig heart mitochondria/microsomes |
| Mammalian alkenyl-GPE acyltransferase | Ethanolamine plasmalogen synthesis | Guinea pig heart microsomes |
| Acyl-GPC acyltransferase | General phospholipid remodeling | Comparison with plasmalogen synthase assays |
Plasmalogen deficiency and neurological disorders
Plasmalogens are abundant in brain membranes, and reduced plasmalogen levels have been observed in neurodegenerative conditions. Because plasmalogen synthase activity is required to produce mature plasmalogens, its dysfunction could contribute to membrane abnormalities in these disorders. However, direct causal links between mutations in plasmalogen synthase and specific neurological diseases have not been established in the cited literature.
Cardiac and metabolic disease
The heart is a rich source of plasmalogens, and plasmalogen synthase activity has been measured in guinea pig heart mitochondria and microsomes. Alterations in plasmalogen metabolism may affect cardiac membrane function and susceptibility to oxidative stress. The cited studies provide biochemical evidence for the activity but do not establish a direct role in human cardiac disease.
Microbial production and biotechnology
Bacterial plasmalogen synthases such as MeHAD enable heterologous production of plasmalogens in E. coli, which can be used to study their biological roles and potential therapeutic applications. This biotechnology angle is relevant for producing plasmalogen standards and for engineering microbial lipids.
From plasmalogen synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of plasmalogen synthase reduce plasmalogen levels? | CRISPR knockout of the candidate gene in a plasmalogen-producing cell line |
| Does a point mutation alter substrate specificity? | CRISPR point mutation knock-in of the catalytic residue |
| Can a tagged enzyme be used for localization studies? | Knock-in of an epitope tag at the endogenous locus |
| Does overexpression increase plasmalogen production? | CRISPR overexpression or cDNA overexpression in E. coli or mammalian cells |
| Which domains are required for activity? | Domain deletion or point mutation via CRISPR |
| Can bacterial enzymes function in mammalian cells? | Heterologous expression of MeHAD or homologs in mammalian cells |
How to Study the plasmalogen synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled acyl-CoA assay | Enzyme activity via product formation | Kinetic characterization of plasmalogen synthase |
| Thin-layer chromatography | Separation of lipid products | Detection of acylated plasmalogen |
| Mass spectrometry lipidomics | Quantification of plasmalogen species | Monitoring plasmalogen production in cells |
| Heterologous expression in E. coli | Functional activity of recombinant enzymes | Testing bacterial plasmalogen synthases |
| Subcellular fractionation | Compartment-specific activity | Comparing mitochondria vs microsomes |
| Enzyme kinetics | Substrate affinity and reaction rate | Characterizing MeHAD and homologs |
| Substrate specificity assays | Preference for alkenyl-GPC vs acyl-GPC | Distinguishing plasmalogen synthase from acyl-GPC acyltransferase |
Biochemical enzyme assays
Plasmalogen synthase activity can be measured using radiolabeled acyl-CoA and lysoplasmalogen substrates, followed by lipid extraction and separation by thin-layer chromatography or high-performance liquid chromatography. These assays allow kinetic characterization and substrate specificity determination.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics can quantify plasmalogen species and detect the product of plasmalogen synthase activity, 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine. This approach is useful for monitoring changes in plasmalogen pools in cells and tissues.
Heterologous expression and recombinant production
Bacterial plasmalogen synthase genes such as MeHAD can be expressed in E. coli to produce plasmalogens, enabling functional studies and production of standards. This system can be used to test enzyme variants and optimize reaction conditions.
Subcellular fractionation
Mitochondria and microsomes can be isolated from tissues such as guinea pig heart to measure plasmalogen synthase activity in different compartments. This method helps distinguish between organelle-specific enzymes and their contributions to plasmalogen synthesis.
How CRISPR Can Be Used to Study GO:0047159 plasmalogen synthase activity
Knockout
CRISPR knockout of a candidate plasmalogen synthase gene can be used to test whether loss of the enzyme reduces cellular plasmalogen levels and alters membrane properties. This approach is applicable to mammalian cell lines and to bacteria for functional genomics.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid substitutions in the catalytic domain of plasmalogen synthase to test mechanism and substrate specificity. Such models help distinguish between catalytic and structural roles of the enzyme.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous plasmalogen synthase locus enables localization and interaction studies without overexpression artifacts. This is useful for tracking the enzyme in mitochondria and microsomes.
Overexpression
CRISPR activation or cDNA overexpression can increase plasmalogen synthase levels to study effects on plasmalogen production and membrane composition. Overexpression in E. coli is particularly useful for recombinant plasmalogen synthesis.
How EDITGENE Supports plasmalogen synthase activity Research
Researchers studying plasmalogen synthase activity-related genes often need to determine whether a candidate gene is causally involved in plasmalogen production, membrane function, or disease. EDITGENE provides CRISPR-based cell models and screening services to enable these functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for plasmalogen synthase activity research.
Frequently Asked Questions About plasmalogen synthase activity
What is plasmalogen synthase activity?
Plasmalogen synthase activity (GO:0047159) is the acyl-CoA-dependent acylation of 1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine to form 1-O-(1Z-alkenyl)-2-acyl-sn-glycero-3-phosphocholine and CoA.
What is the GO ID for plasmalogen synthase activity?
The GO ID is GO:0047159, under the molecular_function ontology.
What reaction does plasmalogen synthase catalyze?
It catalyzes the transfer of an acyl group from acyl-CoA to the sn-2 position of a lysoplasmalogen, producing a mature plasmalogen and CoA.
What genes are involved in plasmalogen synthase activity?
The bacterial gene MeHAD from Megasphaera elsdenii encodes a characterized plasmalogen synthase, and facultative anaerobic bacteria harbor related genes that can be expressed in E. coli.
Where is plasmalogen synthase activity found in cells?
Activity has been detected in guinea pig heart mitochondria and microsomes, indicating membrane-associated localization.
Is plasmalogen synthase the same as acyl-GPC acyltransferase?
No, plasmalogen synthase acts on alkenyl-GPC, while acyl-GPC acyltransferase acts on acyl-GPC; they are distinct activities.
How is plasmalogen synthase activity measured?
It can be measured using radiolabeled acyl-CoA assays, thin-layer chromatography, or mass spectrometry-based lipidomics.
Can plasmalogen synthase be expressed in E. coli?
Yes, recombinant E. coli expressing anaerobic bacterium-derived plasmalogen synthase genes can synthesize plasmalogens aerobically.
What diseases are linked to plasmalogen synthase activity?
Plasmalogen deficiency has been associated with neurological and metabolic conditions, but direct causal links to this enzyme require further study.
How can CRISPR help study plasmalogen synthase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional interrogation of plasmalogen synthase genes in cells and bacteria.
Conclusion
Plasmalogen synthase activity (GO:0047159) is a defined acyltransferase function that produces mature plasmalogens from lysoplasmalogen precursors. Its biochemical characterization in mammalian tissues and the discovery of bacterial enzymes such as MeHAD provide a foundation for studying plasmalogen biology and for engineering microbial plasmalogen production. Researchers can now use CRISPR-based models and lipidomics to test the causal roles of plasmalogen synthase genes in health and disease, and to develop new tools for controlling plasmalogen levels in cells and organisms.
References
- 1. Zhang F et al.. 2023. Characterization and heterologous expression of plasmalogen synthase MeHAD from Megasphaera elsdenii.. Biochim Biophys Acta Mol Cell Biol Lipids 1868(9):159358 PMID: 37348645
- 2. Irimajiri R et al.. 2026. Characterization of plasmalogen production in facultative anaerobic bacteria and aerobic synthesis in recombinant Escherichia coli expressing anaerobic bacterium-derived plasmalogen synthase genes.. Appl Environ Microbiol 92(1):e0094025 PMID: 41427725
- 3. Choy PC et al.. 1997. Acyl-GPC and alkenyl/alkyl-GPC:acyl-CoA acyltransferases.. Biochim Biophys Acta 1348(1-2):124-33 PMID: 9370324
- 4. Arthur G et al.. 1987. The acylation of lysophosphoradylglycerocholines in guinea-pig heart mitochondria.. Biochem J 242(1):171-5 PMID: 3036082
- 5. Arthur G et al.. 1986. Acylation of 1-alkenyl-glycerophosphocholine and 1-acyl-glycerophosphocholine in guinea pig heart.. Biochem J 236(2):481-7 PMID: 3753462
- 6. Arthur G et al.. 1987. Acylation of 1-alkenylglycerophosphoethanolamine and 1-acylglycerophosphoethanolamine in guinea-pig heart microsomes.. Biochim Biophys Acta 921(2):259-65 PMID: 3651487
